secwatch.observer — SEC 8-K summary
======================================

Issuer:     Vera Therapeutics, Inc. (VERA)
CIK:        0001831828
Form:       8-K
Filed at:   2024-10-31T23:59:59+00:00
Accession:  0001193125-24-248079
Event type: other_material
Sentiment:  neutral
Materiality: 0.75
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Vera Therapeutics launches $300M public offering of 7.1M shares at $42.00
-------------------------------------------------------------------------

- 7,142,858 shares offered at $42.00/share; gross proceeds ~$300M before discounts and expenses.
- Underwriters have 30-day option to purchase up to 1,071,428 additional shares at the same price.
- Closing expected October 31, 2024; J.P. Morgan, Goldman Sachs, Evercore, Cantor Fitzgerald are underwriters.
- Offering made under automatic shelf registration statement on Form S-3; customary closing conditions apply.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1831828/000119312524248079/0001193125-24-248079-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1831828/000119312524248079/d787969d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-24-248079

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer